Press Releases

Search Press Releases:

• All News
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010

Tonix Pharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

September 6, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Presented Additional Phase 2 Clinical Results in Military-Related PTSD and Design of Ongoing Phase 3 Trial at the 2017 Military Health System Research Symposium

August 29, 2017 • 4:30 PM EDT

Tonix Pharmaceuticals to Present Additional Phase 2 Clinical Results and Design of Ongoing Phase 3 Trial in Military-Related PTSD at the 2017 Military Health System Research Symposium

August 21, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Programs Update

August 14, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya® as Proposed Brand Name for TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of PTSD

July 6, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present at the 2017 BIO International Convention

June 16, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Participated in the "Pathophysiology of Posttraumatic Stress Disorder: Rethinking Drug Targets” Summit Sponsored by U.S. Department of Defense

June 15, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present an Update of FDA Designated Breakthrough Therapy-TNX-102 SL for PTSD at the 2017 Marcum MicroCap Conference

June 12, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Presented Retrospective Analyses of Treatment Response and Remission to TNX-102 SL in a Phase 2 Military-Related PTSD Study

May 30, 2017 • 4:30 PM EDT

Tonix Pharmaceuticals to Present Additional Clinical Results of Military-Related PTSD Study at the 2017 American Society of Clinical Psychopharmacology Annual Meeting

May 24, 2017 • 7:00 AM EDT

• « Previous
• 1...
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• ...29
• Next »